Table 5.
Baseline laboratory evaluation prior to receiving HIV nPEP medications.
| Cohort N = 151 | |
|---|---|
| Liver transaminases ≥2 SD | 0 (0) |
| Hematocrit <35% | 17 (11) |
| Hematocrit <30% | 3 (2) |
| Thrombocytopenia (150,000 platelets) | 0 (0) |
| Glucose >200 mg% | 2 (1) |
| Hypophosphatemia | 1 (1) |
| Creatinine >1.2 mg/mL | 0 (0) |
| Hepatitis C seropositive | 5 (3) |
| HIV seropositive | 0 (0) |
| Hepatitis B surface antigen | 0 (0) |